fbpx Skip to main content

Biocom California Newsletter Article

Dr. Graham Wood will lead the company’s Minneapolis clinic following the retirement of co-founder, Jeff Cosgrove.

Nucleus Network Welcomes New Executive Vice President

  • 2021-07-22T19:00:00.000+0000
  • California
  • Author: Nucleus Network

This month, Nucleus Network welcomes Dr. Graham Wood as their new Executive Vice President, leading the Minneapolis clinic and Nucleus Network's US operations alongside their two Australian locations, Melbourne and Brisbane. His appointment comes after the planned retirement of current co-founder and leader of the company formerly known as Prism Research, Jeff Cosgrove.

In Jeff’s 30 years of experience in the sector, he has worked in many roles, from recruitment management to operational management before founding Prism Research in 2004. Jeff’s in-depth understanding and experience across the clinical operations value chain has led to the successful execution of over 900 early-phase research protocols since 1990. His understanding of the needs of the sector and ability to recruit and retain an excellent team of people around him helped make Prism an incredible success story.

Jeff has been involved in the selection and handover of the leadership of the site to Dr. Graham Wood, effective July 5.

Dr. Wood is a leader in the conduct and design of clinical pharmacology studies, having held senior executive roles in a number of the top clinical research sites in the world.

In his 22 years of experience, he has been involved with more than 200 first-in-human studies as well as over 2,000 studies across all areas of clinical pharmacology.

After finishing his PhD in Neurology and Neurosurgery, Graham worked at MDS Pharma Services, Cetero Research, Manna Research and Altasciences as well as spending two years working at biotechnology companies. His most recent role was as the Chief Operating Officer at Tetra Bio-Pharma.

Graham joins Nucleus Network to continue to build the industry-leading capabilities of their Minneapolis facility in specialized renal and hepatic studies and healthy volunteer trials. Currently delivering approximately 100 early phase trials annually across our three locations, for their international client base including large Pharmaceutical and biotech companies, he will also support the overall growth of Nucleus Network and further expansion in the US.

Graham’s experience and understanding of the clinical trials sector, along with the already high-performing team at the company's Minneapolis site will no doubt continue the tradition of success that began with Prism Research 15 years ago.

The Nucleus Network team wishes Jeff all the best in retirement and welcomes Dr. Wood into the company. The team looks forward to working with him and the company's clients in advancing medicine and improving lives.